These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 33372557)

  • 1. Pharmacological strategies for smoking cessation in patients with chronic obstructive pulmonary disease: a pragmatic review.
    Antoniu SA; Buculei I; Mihaltan F; Crisan Dabija R; Trofor AC
    Expert Opin Pharmacother; 2021 May; 22(7):835-847. PubMed ID: 33372557
    [No Abstract]   [Full Text] [Related]  

  • 2. Smoking cessation treatment for COPD smokers: the role of pharmacological interventions.
    Jiménez-Ruiz CA; Fagerström KO
    Monaldi Arch Chest Dis; 2013 Mar; 79(1):27-32. PubMed ID: 23741943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost analysis of varenicline versus bupropion, nicotine replacement therapy, and unaided cessation in Nicaragua.
    Lutz MA; Lovato P; Cuesta G
    Hosp Pract (1995); 2012 Feb; 40(1):35-43. PubMed ID: 22406881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacotherapy for smoking cessation in schizophrenia: a systematic review.
    Kozak K; George TP
    Expert Opin Pharmacother; 2020 Apr; 21(5):581-590. PubMed ID: 32011186
    [No Abstract]   [Full Text] [Related]  

  • 5. Smoking and chronic obstructive pulmonary disease (COPD). Parallel epidemics of the 21 century.
    Laniado-Laborín R
    Int J Environ Res Public Health; 2009 Jan; 6(1):209-24. PubMed ID: 19440278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2012 Apr; (4):CD006103. PubMed ID: 22513936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Smoking cessation medicines and e-cigarettes: a systematic review, network meta-analysis and cost-effectiveness analysis.
    Thomas KH; Dalili MN; López-López JA; Keeney E; Phillippo D; Munafò MR; Stevenson M; Caldwell DM; Welton NJ
    Health Technol Assess; 2021 Oct; 25(59):1-224. PubMed ID: 34668482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Smoking cessation: Pharmacological strategies different from standard treatments].
    Underner M; Perriot J; Peiffer G; Harika-Germaneau G; Jaafari N
    Rev Pneumol Clin; 2018 Sep; 74(4):205-214. PubMed ID: 29773262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and tolerability of pharmacotherapies to aid smoking cessation in adolescents.
    Bailey SR; Crew EE; Riske EC; Ammerman S; Robinson TN; Killen JD
    Paediatr Drugs; 2012 Apr; 14(2):91-108. PubMed ID: 22248234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2011 Feb; (2):CD006103. PubMed ID: 21328282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2010 Dec; (12):CD006103. PubMed ID: 21154363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of varenicline or bupropion and its association with nicotine metabolite ratio among smokers with COPD.
    Qin R; Liu Z; Cheng AQ; Zhou XM; Su Z; Cui ZY; Li JX; Wei XW; Zhao L; Chung KF; Xiao D; Wang C
    Respirology; 2024 Jun; 29(6):479-488. PubMed ID: 38494828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of COPD smokers and effectiveness and safety of smoking cessation medications.
    Jiménez Ruiz CA; Ramos Pinedo A; Cicero Guerrero A; Mayayo Ulibarri M; Cristobal Fernández M; Lopez Gonzalez G
    Nicotine Tob Res; 2012 Sep; 14(9):1035-9. PubMed ID: 22345320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost effectiveness of varenicline in Belgium, compared with bupropion, nicotine replacement therapy, brief counselling and unaided smoking cessation: a BENESCO Markov cost-effectiveness analysis.
    Annemans L; Nackaerts K; Bartsch P; Prignot J; Marbaix S
    Clin Drug Investig; 2009; 29(10):655-65. PubMed ID: 19715382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smoking cessation and vaccination.
    Montes de Oca M; Laucho-Contreras ME
    Eur Respir Rev; 2023 Mar; 32(167):. PubMed ID: 36948500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness analysis of varenicline versus existing smoking cessation strategies in Central America and the Caribbean using the BENESCO model.
    Lutz MA; Lovato P; Cuesta G
    Hosp Pract (1995); 2012 Feb; 40(1):24-34. PubMed ID: 22406880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-utility analysis of varenicline versus existing smoking cessation strategies using the BENESCO Simulation model: application to a population of US adult smokers.
    Howard P; Knight C; Boler A; Baker C
    Pharmacoeconomics; 2008; 26(6):497-511. PubMed ID: 18489200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 'Real-world' effectiveness of smoking cessation treatments: a population study.
    Kotz D; Brown J; West R
    Addiction; 2014 Mar; 109(3):491-9. PubMed ID: 24372901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Which is the best primary medication for long-term smoking cessation--nicotine replacement therapy, bupropion or varenicline?
    Doggrell SA
    Expert Opin Pharmacother; 2007 Dec; 8(17):2903-15. PubMed ID: 18001252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Smoking cessation.
    Rennard SI; Daughton DM
    Clin Chest Med; 2014 Mar; 35(1):165-76. PubMed ID: 24507844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.